GL1X · GenesisL1 explorer

Research workbench

Crystal structures of a multidrug-resistant HIV-1 protease reveal an expanded active site cavity

Analyse Crystal structures of a multidrug-resistant HIV-1 protease reveal an expanded… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1RQ9
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
EC
3.4.23.16
Ligands
DMQ
Pockets
1 · best druggability 0.55

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease (EC 3.4.23.16)protein997% helix, 48% strand—

Ligands and binding sites

  • DMQ · [4-R-(-4-alpha,5-alpha,6-beta,7-beta)]-hexahydro-5,6-bis(hydroxy)-1,3-bis([(3-amino)phenyl]methyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepinone · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14080.550.7339DMQ

Interfaces

1 interface between chains.

  • A–B · 1505 Ų buried · 39 hydrogen bonds · protein-protein

Compared structures

  • 1RQ9 · Crystal structures of a Multidrug-Resistant HIV-1 Protease Reveal an Expanded Active Site… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.